Dr. Lohmer has been with Nuventra for 5+ years and has experience in all stages of development, with specific interest in concentration-QT analysis and pediatric study plans. She has worked on 18+ approved drugs, NDAs, INDs, protocols, PK analyses, and population PK analyses. Dr. Lohmer’s PK and PK/PD experience covers nonclinical, clinical, and post-marketing; an extensive range of therapeutic areas; and a wide variety of regulatory interactions, regulatory meetings, and regulatory submissions.
Education